Auto-generated from public data. Not the firm's stated position.
HCS Beteiligungsgesellschaft appears to focus on growth-stage and Series C investments across diversified sectors including biotech, AI, robotics, and edtech, with a typical check size around €3.0M. Recent portfolio activity suggests interest in both deep tech and consumer-adjacent applications, spanning medical devices, gaming nutrition, and IT services. The firm's investment thesis based on disclosed data indicates a preference for established companies transitioning through growth phases rather than early-stage ventures.
Generated 9 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].
Auto-detected from HCS Beteiligungsgesellschaft's website.
Former investment banking and finance executive with extensive board experience.
Experienced in leadership and advisory roles at major mid-market companies.
Focus and check size from the firm's website. Website reachable as of Sept 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.